Chirality 1999-01-01

Epimerization of moxalactam by albumin and simulation of in vivo epimerization by a physiologically based pharmacokinetic model.

T Yoshikawa, T Oguma, T Ichihashi, H Kinoshita, K Hirano, H Yamada

Index: Chirality 11(4) , 309-15, (1999)

Full Text: HTML

Abstract

We investigated the mechanism of epimerization (R to S or S to R) of moxalactam in serum of rats, dogs, and humans. The epimerization of moxalactam occurred in the serum of these animals, but not in the serum filtrate. The albumin fraction of human serum purified by gel filtration catalysed the epimerization of moxalactam at an identical rate to serum, but other fractions (i.e., lipoproteins and globulins) showed slower epimerization. alpha 1-acid glycoprotein, which was eluted in the same fraction with albumin by G-200 gel filtration, did not epimerize moxalactam. The presence of 2 mM warfarin decreased the binding of R- and S-moxalactam and decreased the epimerization of moxalactam in human serum. These results demonstrate moxalactam was epimerized on the warfarin binding site on albumin in serum. Additionally, a physiologically based pharmacokinetic model shows that the epimerization of moxalactam after administration in dogs is simulated by the epimerization in serum.

Related Compounds

  • Latamoxef

Related Articles:

A potential substrate binding conformation of β-lactams and insight into the broad spectrum of NDM-1 activity.

2012-10-01

[Antimicrob. Agents Chemother. 56(10) , 5157-63, (2012)]

Comparison of cefoxitin and moxalactam 30 microg disc diffusion methods for detection of methicillin resistance in coagulase-negative staphylococci.

2007-04-01

[J. Antimicrob. Chemother. 59(4) , 763-6, (2007)]

Phosphate deprivation is associated with high resistance to latamoxef of gel-entrapped, sessile-like Escherichia coli cells.

2002-02-01

[J. Antimicrob. Chemother. 49(2) , 315-20, (2002)]

Subclinical syphilitic hepatitis, which was markedly worsened by a Jarisch-Herxheimer reaction.

1999-06-01

[Am. J. Gastroenterol. 94(6) , 1694-6, (1999)]

Inhibition of AmpC beta-lactamase through a destabilizing interaction in the active site.

2001-07-10

[Biochemistry 40(27) , 7992-9, (2001)]

More Articles...